Established in 1988, Xiehe Group Co., Ltd. is a knowledge and technology intensive high-tech enterprise. The company adopts super-antigen theory and gene engineering technology as platforms, engages in the development, production and sales of bio-pharmaceutical drugs, traditional Chinese medicines and dietary supplements. Its solely developed, world advanced superantigen serial biodrugs and healthcare products have achieved significant results in the prevention and treatment of severe diseases such ad cancer and AIDS etc.

As a High and New Technology Enterprises assessed by Torch Center of National Ministry of Science and Technology, Xiehe Group owns a modern pharmaceutical plant which has passed GMP and ISO9001 certification. Xiehe Group has undertaken projects of China National Torch Plan for many times, such as research of anti-tumor and anti-AIDS bio-medicine, separation and preparation of 150 kinds of standard controls of TCM(Traditional Chinese Medicine).

Xiehe Group pays close attention to scientific research and development, advocates technical creation and has established cooperation relationship with famous scientific institutions and universities such as Chinese Academy of Medical Sciences, Tsinghua University, Chinese Military Medicine Science College, Shanghai Medical University, The Chinese University of Hong Kong, Harvard Medical School and McGill University Medical School，etc.

As a famous enterprise, Xiehe Group also rewards society through charity donation. The group has donated over RMB 180 million in goods and money to cancer and AIDS patients and people who need help in China and such countries as India, Philippine, South Africa, Congo, Niger and Mali. In year 2014, Xiehe Group’s donation to Ebola virus stricken African countries was highly appreciated by the presidents of Sierra Leone, Liberia, Nigeria and Guinea Bissau.

    As a subordinate company of Xiehe Group, Shenyang Xiehe Bio-pharmaceutical Co., Ltd. owns a modern GMP pharmaceutical plant certified by China’s FDA. Its patent-protected biological drug has been used clinically for more than 20 years mainly in the prevention and treatment of cancer and viral diseases (such as AIDS, hepatitis B, atypical pneumonia, Ebola virus and etc.).